Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial

Psychopharmacology
Pim R A HeckmanAnke Sambeth

Abstract

Sensory gating is a process involved in early information processing which prevents overstimulation of higher cortical areas by filtering sensory information. Research has shown that the process of sensory gating is disrupted in patients suffering from clinical disorders including attention deficit hyper activity disorder, schizophrenia, and Alzheimer's disease. Phosphodiesterase (PDE) inhibitors have received an increased interest as a tool to improve cognitive performance in both animals and man, including sensory gating. The current study investigated the effects of the PDE4 inhibitor roflumilast in a sensory gating paradigm in 20 healthy young human volunteers (age range 18-30 years). We applied a placebo-controlled randomized cross-over design and tested three doses (100, 300, 1000 μg). Results show that roflumilast improves sensory gating in healthy young human volunteers only at the 100-μg dose. The effective dose of 100 μg is five times lower than the clinically approved dose for the treatment of acute exacerbations in chronic obstructive pulmonary disease (COPD). No side-effects, such as nausea and emesis, were observed at this dose. This means roflumilast shows a beneficial effect on gating at a dose that had no adver...Continue Reading

Associated Clinical Trials

References

Apr 1, 1983·Electroencephalography and Clinical Neurophysiology·G GrattonE Donchin
Aug 1, 1996·Biological Psychiatry·H T NagamotoR Freedman
Oct 6, 1999·Biological Psychiatry·G A LightD L Braff
May 2, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L E AdlerR Freedman
Jun 16, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Li WanNash Boutros
Feb 14, 2006·Schizophrenia Bulletin·David PotterRobert W Buchanan
Feb 3, 2007·American Journal of Alzheimer's Disease and Other Dementias·Brandon A AllyAndrew E Budson
Dec 8, 2007·Nature Reviews. Drug Discovery·Daniel C JavittMihály Hajós
Feb 22, 2008·The Journal of Pharmacology and Experimental Therapeutics·C J SchmidtF S Menniti
Aug 19, 2008·Psychopharmacology·Olga A H ReneerkensJos Prickaerts
Nov 10, 2009·Cognitive, Affective & Behavioral Neuroscience·Carly A YadonDeana B Davalos
Nov 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Gezim LahuAndreas Hünnemeyer
Feb 14, 2012·The Journal of Pharmacology and Experimental Therapeutics·Robin J KleimanChristopher J Schmidt
Aug 3, 2012·Psychopharmacology·O A H ReneerkensJ Prickaerts
May 22, 2013·Behavioural Brain Research·O A H ReneerkensJ Prickaerts
Jun 24, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Signe DüringBob Oranje
Dec 3, 2014·European Journal of Pharmacology·Sobhana George Sugin Lal JabarisChidambaram Saravana Babu
Dec 3, 2014·Neurobiology of Learning and Memory·P R A HeckmanJ Prickaerts
Apr 1, 2015·European Journal of Pharmacology·Arjan BloklandAnke Sambeth
Jul 2, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Louise WittenBob Oranje
Jan 23, 2016·Behavioural Brain Research·Tim VanmierloJos Prickaerts
Apr 3, 2016·The International Journal of Neuropsychopharmacology·Pim R A HeckmanJos Prickaerts

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

SPSS Statistics
Vision Analyzer

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.